TUHURA BIOSCIENCES ANNOUNCES ITS RELEASE OF KINTARA'S CONTINGENT VALUE RIGHT (CVR) AS KINTARA'S REM-001 MEETS PRIMARY SAFETY ENDPOINT ACHIEVING CONTRACTUAL MILESTONE
Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.